Cancer Research

Can New Drug Discoveries Finally Treat Rare Bone Cancer Chordoma?
Research & Development Can New Drug Discoveries Finally Treat Rare Bone Cancer Chordoma?

Chordoma, a rare bone cancer affecting about one in a million people, has long been a medical enigma. Historically, the lack of understanding and effective treatments has rendered it untreatable. However, recent breakthroughs by Professor Paul Workman and his team offer new hope. This article

Daily Calcium Intake Linked to Lower Bowel Cancer Risk, Study Shows
Research & Development Daily Calcium Intake Linked to Lower Bowel Cancer Risk, Study Shows

Increasing incidences of bowel cancer are an alarming public health issue, so researchers have been examining dietary factors that might mitigate this risk. Recent research has indicated that calcium, a mineral predominantly found in dairy products, plays a protective role in preventing bowel

Kids First Releases Datasets to Advance Pediatric Genetic Research
Research & Development Kids First Releases Datasets to Advance Pediatric Genetic Research

In a significant step toward understanding and combating childhood cancers and congenital disorders, the Gabriella Miller Kids First Pediatric Research Program (Kids First), an initiative of the National Institutes of Health (NIH), has released two comprehensive new datasets. Focusing on childhood

Can Zai Lab's ZL-1310 Revolutionize Small Cell Lung Cancer Treatment?
Research & Development Can Zai Lab's ZL-1310 Revolutionize Small Cell Lung Cancer Treatment?

The recent Orphan Drug Designation (ODD) granted by the U.S. Food and Drug Administration (FDA) to Zai Lab Limited for their drug ZL-1310 marks a significant milestone in the fight against small cell lung cancer (SCLC). This promising Delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC) is

Allarity Therapeutics Expands Phase 2 Trial of Stenoparib for Ovarian Cancer
Research & Development Allarity Therapeutics Expands Phase 2 Trial of Stenoparib for Ovarian Cancer

Allarity Therapeutics, Inc. has announced the expansion of their Phase 2 clinical trial for stenoparib, a dual PARP/Wnt pathway inhibitor, aimed at treating advanced ovarian cancer. Their recent decision seeks to accelerate the drug's clinical development and work towards FDA regulatory approval.

Proteo-Genomics Study Reveals New Insights Into Gut Microbiome and Health
Research & Development Proteo-Genomics Study Reveals New Insights Into Gut Microbiome and Health

The human gut microbiome plays a crucial role in overall health, influencing everything from digestion to immune function. Recent advancements in proteo-genomics have provided unprecedented insights into the complex interactions within the gut microbiome. A groundbreaking study has utilized

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later